Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,840 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival outcomes of east Asian patients with advanced non-small cell lung cancer treated with first-line EGFR tyrosine kinase inhibitors: A network meta-analysis of real-world evidence.
Chang HC, Huang KT, Tseng CC, Chen YM, Lai CH, Chang YP, Chen YC, Chuang HY, Wang CC. Chang HC, et al. Among authors: chen ym, chen yc. Thorac Cancer. 2023 Nov;14(32):3217-3225. doi: 10.1111/1759-7714.15112. Epub 2023 Sep 13. Thorac Cancer. 2023. PMID: 37704454 Free PMC article.
Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM, Lai CH, Chang HC, Chao TY, Tseng CC, Fang WF, Wang CC, Chung YH, Wang YH, Su MC, Huang KT, Chen HC, Chang YC, Lin MC. Chen YM, et al. Among authors: chen hc. PLoS One. 2015 Aug 27;10(8):e0136252. doi: 10.1371/journal.pone.0136252. eCollection 2015. PLoS One. 2015. PMID: 26313661 Free PMC article.
Baseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM, Lai CH, Chang HC, Chao TY, Tseng CC, Fang WF, Wang CC, Chung YH, Huang KT, Chen HC, Chang YC, Lin MC. Chen YM, et al. Among authors: chen hc. Medicine (Baltimore). 2015 Dec;94(50):e2239. doi: 10.1097/MD.0000000000002239. Medicine (Baltimore). 2015. PMID: 26683939 Free PMC article.
Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Chen YM, Lai CH, Chang HC, Chao TY, Tseng CC, Fang WF, Wang CC, Chung YH, Wang YH, Su MC, Liu SF, Huang KT, Chen HC, Chang YC, Lin MC. Chen YM, et al. Among authors: chen hc. PLoS One. 2016 Feb 19;11(2):e0149722. doi: 10.1371/journal.pone.0149722. eCollection 2016. PLoS One. 2016. PMID: 26894507 Free PMC article.
2,840 results